|
Disclosure of financial relationships
|
145 (89%)
|
|
Of author(s)
|
145 (89)
|
|
Of author’s institution
|
40 (25)
|
|
Of author’s family member(s)
|
17 (10)
|
|
Not explicitly required
|
18 (11)
|
|
Of other
|
1 (0)
|
|
Types of financial disclosure
|
|
Stock ownership
|
83 (51)
|
|
Grant/research support
|
73 (45)
|
|
Direct employment
|
73 (45)
|
|
Serving as an advisor, consultant, or public advocate
|
70 (43)
|
|
Honoraria for speaking, writing, or reviewing on the topic discussed in the manuscript
|
53 (33)
|
|
Personal fees
|
50 (31)
|
|
Indirect financial support
|
47 (29)
|
|
Speaker bureaus or board membership
|
37 (23)
|
|
Royalties
|
26 (16)
|
|
Other type of financial COI
|
4 (3)
|
|
Required but did not specify which types of financial COI
|
40 (25)
|
|
Not required
|
28 (17)
|
|
Duration for which to disclose financial COI
|
|
Not specified
|
142 (87)
|
|
Yes, for the previous number of months
|
20 (12)
|
|
Yes, irrespective of timing (i.e., at any time)
|
1 (1)
|
|
Number of months of required duration (N = 20)
|
|
Within 12 months
|
0 (0)
|
|
12 months
|
0 (0)
|
|
24 months
|
1 (5)
|
|
36 months
|
18 (90)
|
|
4 years
|
0 (0)
|
|
5 years
|
1 (5)
|
|
> 5 years
|
0 (0)
|
|
Time frame for financial COI disclosure
|
|
Time of the submission
|
11 (7)
|
|
At the initiation of the study
|
5 (3)
|
|
Not specified
|
4 (3)
|
|
Required disclosure of financial COI in the near future
|
12 (7)
|
|
Required duration of financial COI outside submitted work
|
1 (0)
|
|
Explicitly required source of financial benefit
|
64 (39)
|
|
Required monetary value of financial benefit
|
|
Not required
|
162 (100)
|
|
Yes, irrespective of amount
|
1 (0)
|
|
Yes, for amounts above a specific value
|
0 (0)
|
|
Required disclosure of any patents
|
63 (41)
|
